The overall theme of this thesis is to generate innovative health-economic outcomes which are needed prior to the introduction of population-level dengue immunization programs in three dengue-endemic countries: Vietnam, Thailand, and Colombia. This thesis consists of six chapters which are distinctive but inter-related. Following the introductory chapter, where the existing literature search is carried out, in Chapter 2 I begin by conducting a multi-country study of the economic burden of dengue fever based on standardized field studies in the three dengue-endemic countries. In Chapter 3, an Early Warning Signal (EWS) model is developed based upon climate and non-climate factors. In particular, this chapter adopts a theory of elasticity, w...
Background: Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion peop...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion people in the tr...
The overall theme of this thesis is to generate innovative health-economic outcomes which are needed...
Background The dengue vaccination era began when Dengvaxia (CYD-TDV) became available in 2016. In ad...
The rise in dengue fever cases and the absence of dengue vaccines will likely cause governments to c...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
BACKGROUND:The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health sys...
Dengue is the most rapidly spreading mosquito-borne viral disease in humans, causing around 58.4 mil...
AbstractA dengue vaccine is likely to be available within the next 3-5 years and we estimated vaccin...
Over the past half-century dengue has re-emerged as a major public health challenge throughout the t...
, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In antici...
Dengue has become one of the most important vector borne diseases endangering human health. The burd...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
Background: Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion peop...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion people in the tr...
The overall theme of this thesis is to generate innovative health-economic outcomes which are needed...
Background The dengue vaccination era began when Dengvaxia (CYD-TDV) became available in 2016. In ad...
The rise in dengue fever cases and the absence of dengue vaccines will likely cause governments to c...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
With several candidate dengue vaccines under development, this is an important time to help stakehol...
BACKGROUND:The incidence of dengue fever (DF) is steadily increasing in Mexico, burdening health sys...
Dengue is the most rapidly spreading mosquito-borne viral disease in humans, causing around 58.4 mil...
AbstractA dengue vaccine is likely to be available within the next 3-5 years and we estimated vaccin...
Over the past half-century dengue has re-emerged as a major public health challenge throughout the t...
, 2015, Mexico became the first country for which the dengue vaccine was approved for use. In antici...
Dengue has become one of the most important vector borne diseases endangering human health. The burd...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
Background: Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion peop...
The tetravalent dengue vaccine CYD-TDV (Dengvaxia) is the first licensed vaccine against dengue, but...
Dengue illness causes 50–100 million infections worldwide and threatens 2.5 billion people in the tr...